DURHAM, N.C., August 7, 2017 — Premier Research announces the appointment of Nach Davé, RPh, MS, as Vice President of Global Regulatory Affairs. He oversees the company’s regulatory affairs service offerings in rare diseases and across its broad range of therapeutic focus areas, bringing to the position more than 20 years of experience in the pharmaceutical and contract research industries.
Mr. Davé, who previously was Director of Regulatory Affairs at Premier Research, rejoins the company after two years as Senior Director of Regulatory Affairs at PRA Health Sciences. He also led clinical and regulatory affairs at Maxx Orthopedics, a developer of orthopedic medical devices.
He also has held roles in clinical operations, business development, strategic consulting, and medical affairs at companies such as Merck, Bristol-Myers Squibb, Aventis Pharmaceuticals, and Mitsubishi Pharma America.
“Nach’s wide range of clinical and regulatory expertise makes him a great fit for our top regulatory affairs position,” said Colin Hayward, Premier Research’s Chief Medical Officer. “With his diverse experience across the pharma and CRO sectors, Nach will be key in supporting our customers’ drug and device development needs – an enormous asset to our customers who include some of the industry’s most forward-leaning and innovative biotech and specialty pharma companies.”
Mr. Davé holds a master’s degree in drug regulatory affairs from Long Island University and a bachelor’s degree in pharmacy from the Philadelphia College of Pharmacy and Sciences. He is a registered pharmacist in the state of New Jersey.
About Premier Research
Premier Research is a leading clinical development service provider that helps highly innovative biotech and specialty pharma companies transform breakthrough ideas into reality. The company has a wealth of experience in the execution of global, regional and local clinical development programs with a special focus on addressing unmet needs in areas such as analgesia, dermatology, medical device, neuroscience, oncology, pediatric, and rare disease. Premier Research operates in 84 countries and employs 1,100 professionals, including a strong international network of clinical monitors and project managers, regulatory, data management, statistical, scientific, and medical experts. They are focused on smart study design for advanced medicines that allow life-changing treatments.